John Freshley, Angel Investor

John Prista Freshley is an entrepreneur, company builder, and angel investor with 20+ years of experience in start-up and emerging bioscience companies. His strengths and true expertise lie in the earliest stage of science commercialization especially in regions where early capital can be scarce. This is also the challenge I most enjoy. He is the Chairman of Bioscience Navigators, a company that is dedicated to providing hands-on experienced business leadership for breakthrough science from universities and start-ups in often overlooked regions that will create attractive investor returns, the next-generation bioscience leadership talent, and vibrant and sustainable bioscience ecosystems. He is also the Executive Chairman of Akeila Bio, a firm that is developing next-generation RXR drugs to treat a wide range of diseases with major unmet patient needs. In addition, he is also the Executive Chairman of CURIO Genomics.